Crossref
A lactylation-associated transcriptomic signature predicts outcome and identifies CBX3 dependency in multiple myeloma
American Journal of Cancer Research · 2026 · 16 (10) · 4407-4422
DOI: 10.62347/tgjc7155 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Qian Hu und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hu, Q., Tao, Y., Wu, D., Xu, J., Pan, H., Liu, Y., & Niu, T. (2026). A lactylation-associated transcriptomic signature predicts outcome and identifies CBX3 dependency in multiple myeloma. American Journal of Cancer Research, 16(10), 4407-4422. https://doi.org/10.62347/tgjc7155
Vancouver
Hu Q, Tao Y, Wu D, Xu J, Pan H, Liu Y, et al. A lactylation-associated transcriptomic signature predicts outcome and identifies CBX3 dependency in multiple myeloma. American Journal of Cancer Research. 2026;16(10):4407-4422. doi:10.62347/tgjc7155
BibTeX
@article{Hu2026,
author = {Hu, Qian and Tao, Yali and Wu, Daiqian and Xu, Jing and Pan, Hui and Liu, Yu and Niu, Ting},
title = {A lactylation-associated transcriptomic signature predicts outcome and identifies CBX3 dependency in multiple myeloma},
journal = {American Journal of Cancer Research},
year = {2026},
volume = {16},
number = {10},
pages = {4407--4422},
doi = {10.62347/tgjc7155}
}
EUVIMED